Myeloid cells in SCID-beige mice can be induced to produce IL-1, IL-6, and nitric oxide after CAR infusions, leading to tumor-unrelated activity reduction, malaise, piloerection, weight loss, and mortality in CAR-treated animals, serving as a CRS model [120]. The gene discussed is IL6; the disease is congenital rubella syndrome.